Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer
Occult peritoneal metastasis (PM) in advanced gastric cancer (AGC) patients is highly possible to be missed on computed tomography (CT) images. Patients with occult PMs are subject to late detection or even improper surgical treatment. We therefore aimed to develop a radiomic nomogram to preoperativ...
Saved in:
Published in | Annals of oncology Vol. 30; no. 3; pp. 431 - 438 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.03.2019
Oxford University Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Occult peritoneal metastasis (PM) in advanced gastric cancer (AGC) patients is highly possible to be missed on computed tomography (CT) images. Patients with occult PMs are subject to late detection or even improper surgical treatment. We therefore aimed to develop a radiomic nomogram to preoperatively identify occult PMs in AGC patients.
A total of 554 AGC patients from 4 centers were divided into 1 training, 1 internal validation, and 2 external validation cohorts. All patients’ PM status was firstly diagnosed as negative by CT, but later confirmed by laparoscopy (PM-positive n = 122, PM-negative n = 432). Radiomic signatures reflecting phenotypes of the primary tumor (RS1) and peritoneum region (RS2) were built as predictors of PM from 266 quantitative image features. Individualized nomograms of PM status incorporating RS1, RS2, or clinical factors were developed and evaluated regarding prediction ability.
RS1, RS2, and Lauren type were significant predictors of occult PM (all P < 0.05). A nomogram of these three factors demonstrated better diagnostic accuracy than the model with RS1, RS2, or clinical factors alone (all net reclassification improvement P < 0.05). The area under curve yielded was 0.958 [95% confidence interval (CI) 0.923–0.993], 0.941 (95% CI 0.904–0.977), 0.928 (95% CI 0.886–0.971), and 0.920 (95% CI 0.862–0.978) for the training, internal, and two external validation cohorts, respectively. Stratification analysis showed that this nomogram had potential generalization ability.
CT phenotypes of both primary tumor and nearby peritoneum are significantly associated with occult PM status. A nomogram of these CT phenotypes and Lauren type has an excellent prediction ability of occult PM, and may have significant clinical implications on early detection of occult PM for AGC. |
---|---|
AbstractList | Abstract
Background
Occult peritoneal metastasis (PM) in advanced gastric cancer (AGC) patients is highly possible to be missed on computed tomography (CT) images. Patients with occult PMs are subject to late detection or even improper surgical treatment. We therefore aimed to develop a radiomic nomogram to preoperatively identify occult PMs in AGC patients.
Patients and methods
A total of 554 AGC patients from 4 centers were divided into 1 training, 1 internal validation, and 2 external validation cohorts. All patients' PM status was firstly diagnosed as negative by CT, but later confirmed by laparoscopy (PM-positive n = 122, PM-negative n = 432). Radiomic signatures reflecting phenotypes of the primary tumor (RS1) and peritoneum region (RS2) were built as predictors of PM from 266 quantitative image features. Individualized nomograms of PM status incorporating RS1, RS2, or clinical factors were developed and evaluated regarding prediction ability.
Results
RS1, RS2, and Lauren type were significant predictors of occult PM (all P < 0.05). A nomogram of these three factors demonstrated better diagnostic accuracy than the model with RS1, RS2, or clinical factors alone (all net reclassification improvement P < 0.05). The area under curve yielded was 0.958 [95% confidence interval (CI) 0.923-0.993], 0.941 (95% CI 0.904-0.977), 0.928 (95% CI 0.886-0.971), and 0.920 (95% CI 0.862-0.978) for the training, internal, and two external validation cohorts, respectively. Stratification analysis showed that this nomogram had potential generalization ability.
Conclusion
CT phenotypes of both primary tumor and nearby peritoneum are significantly associated with occult PM status. A nomogram of these CT phenotypes and Lauren type has an excellent prediction ability of occult PM, and may have significant clinical implications on early detection of occult PM for AGC. Occult peritoneal metastasis (PM) in advanced gastric cancer (AGC) patients is highly possible to be missed on computed tomography (CT) images. Patients with occult PMs are subject to late detection or even improper surgical treatment. We therefore aimed to develop a radiomic nomogram to preoperatively identify occult PMs in AGC patients. A total of 554 AGC patients from 4 centers were divided into 1 training, 1 internal validation, and 2 external validation cohorts. All patients’ PM status was firstly diagnosed as negative by CT, but later confirmed by laparoscopy (PM-positive n = 122, PM-negative n = 432). Radiomic signatures reflecting phenotypes of the primary tumor (RS1) and peritoneum region (RS2) were built as predictors of PM from 266 quantitative image features. Individualized nomograms of PM status incorporating RS1, RS2, or clinical factors were developed and evaluated regarding prediction ability. RS1, RS2, and Lauren type were significant predictors of occult PM (all P < 0.05). A nomogram of these three factors demonstrated better diagnostic accuracy than the model with RS1, RS2, or clinical factors alone (all net reclassification improvement P < 0.05). The area under curve yielded was 0.958 [95% confidence interval (CI) 0.923–0.993], 0.941 (95% CI 0.904–0.977), 0.928 (95% CI 0.886–0.971), and 0.920 (95% CI 0.862–0.978) for the training, internal, and two external validation cohorts, respectively. Stratification analysis showed that this nomogram had potential generalization ability. CT phenotypes of both primary tumor and nearby peritoneum are significantly associated with occult PM status. A nomogram of these CT phenotypes and Lauren type has an excellent prediction ability of occult PM, and may have significant clinical implications on early detection of occult PM for AGC. Occult peritoneal metastasis (PM) in advanced gastric cancer (AGC) patients is highly possible to be missed on computed tomography (CT) images. Patients with occult PMs are subject to late detection or even improper surgical treatment. We therefore aimed to develop a radiomic nomogram to preoperatively identify occult PMs in AGC patients.BACKGROUNDOccult peritoneal metastasis (PM) in advanced gastric cancer (AGC) patients is highly possible to be missed on computed tomography (CT) images. Patients with occult PMs are subject to late detection or even improper surgical treatment. We therefore aimed to develop a radiomic nomogram to preoperatively identify occult PMs in AGC patients.A total of 554 AGC patients from 4 centers were divided into 1 training, 1 internal validation, and 2 external validation cohorts. All patients' PM status was firstly diagnosed as negative by CT, but later confirmed by laparoscopy (PM-positive n = 122, PM-negative n = 432). Radiomic signatures reflecting phenotypes of the primary tumor (RS1) and peritoneum region (RS2) were built as predictors of PM from 266 quantitative image features. Individualized nomograms of PM status incorporating RS1, RS2, or clinical factors were developed and evaluated regarding prediction ability.PATIENTS AND METHODSA total of 554 AGC patients from 4 centers were divided into 1 training, 1 internal validation, and 2 external validation cohorts. All patients' PM status was firstly diagnosed as negative by CT, but later confirmed by laparoscopy (PM-positive n = 122, PM-negative n = 432). Radiomic signatures reflecting phenotypes of the primary tumor (RS1) and peritoneum region (RS2) were built as predictors of PM from 266 quantitative image features. Individualized nomograms of PM status incorporating RS1, RS2, or clinical factors were developed and evaluated regarding prediction ability.RS1, RS2, and Lauren type were significant predictors of occult PM (all P < 0.05). A nomogram of these three factors demonstrated better diagnostic accuracy than the model with RS1, RS2, or clinical factors alone (all net reclassification improvement P < 0.05). The area under curve yielded was 0.958 [95% confidence interval (CI) 0.923-0.993], 0.941 (95% CI 0.904-0.977), 0.928 (95% CI 0.886-0.971), and 0.920 (95% CI 0.862-0.978) for the training, internal, and two external validation cohorts, respectively. Stratification analysis showed that this nomogram had potential generalization ability.RESULTSRS1, RS2, and Lauren type were significant predictors of occult PM (all P < 0.05). A nomogram of these three factors demonstrated better diagnostic accuracy than the model with RS1, RS2, or clinical factors alone (all net reclassification improvement P < 0.05). The area under curve yielded was 0.958 [95% confidence interval (CI) 0.923-0.993], 0.941 (95% CI 0.904-0.977), 0.928 (95% CI 0.886-0.971), and 0.920 (95% CI 0.862-0.978) for the training, internal, and two external validation cohorts, respectively. Stratification analysis showed that this nomogram had potential generalization ability.CT phenotypes of both primary tumor and nearby peritoneum are significantly associated with occult PM status. A nomogram of these CT phenotypes and Lauren type has an excellent prediction ability of occult PM, and may have significant clinical implications on early detection of occult PM for AGC.CONCLUSIONCT phenotypes of both primary tumor and nearby peritoneum are significantly associated with occult PM status. A nomogram of these CT phenotypes and Lauren type has an excellent prediction ability of occult PM, and may have significant clinical implications on early detection of occult PM for AGC. |
Author | Tian, J. Shan, X -H Sun, Y -S Li, L -M Ji, J.-F. Tang, L. Li, Z -Y Shan, F. Bu, Z -D Wang, X -X Gao, J -B Zhang, Y. Zhang, D -F Fang, M -J Dong, D. Li, Z -H Li, Z -M Ying, X -J Fu, J. |
AuthorAffiliation | 2 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Radiology Department, , Peking University Cancer Hospital & Institute, Beijing 7 Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming 1 CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 5 Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 8 Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Medicine, Beihang University, Beijing, China 3 University of Chinese Academy of Sciences, Beijing 6 Department of Radiology, Affiliated People’s Hospital of Jiangsu University, Zhenjiang 4 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing |
AuthorAffiliation_xml | – name: 6 Department of Radiology, Affiliated People’s Hospital of Jiangsu University, Zhenjiang – name: 7 Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming – name: 2 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Radiology Department, , Peking University Cancer Hospital & Institute, Beijing – name: 1 CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing – name: 5 Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou – name: 3 University of Chinese Academy of Sciences, Beijing – name: 8 Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Medicine, Beihang University, Beijing, China – name: 4 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing |
Author_xml | – sequence: 1 givenname: D. surname: Dong fullname: Dong, D. organization: CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing – sequence: 2 givenname: L. surname: Tang fullname: Tang, L. organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Radiology Department, , Peking University Cancer Hospital & Institute, Beijing – sequence: 3 givenname: Z -Y surname: Li fullname: Li, Z -Y organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing – sequence: 4 givenname: M -J surname: Fang fullname: Fang, M -J organization: CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing – sequence: 5 givenname: J -B surname: Gao fullname: Gao, J -B organization: Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou – sequence: 6 givenname: X -H surname: Shan fullname: Shan, X -H organization: Department of Radiology, Affiliated People’s Hospital of Jiangsu University, Zhenjiang – sequence: 7 givenname: X -J surname: Ying fullname: Ying, X -J organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing – sequence: 8 givenname: Y -S surname: Sun fullname: Sun, Y -S organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Radiology Department, , Peking University Cancer Hospital & Institute, Beijing – sequence: 9 givenname: J. surname: Fu fullname: Fu, J. organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Radiology Department, , Peking University Cancer Hospital & Institute, Beijing – sequence: 10 givenname: X -X surname: Wang fullname: Wang, X -X organization: Department of Radiology, Affiliated People’s Hospital of Jiangsu University, Zhenjiang – sequence: 11 givenname: L -M surname: Li fullname: Li, L -M organization: Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou – sequence: 12 givenname: Z -H surname: Li fullname: Li, Z -H organization: Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming – sequence: 13 givenname: D -F surname: Zhang fullname: Zhang, D -F organization: Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming – sequence: 14 givenname: Y. surname: Zhang fullname: Zhang, Y. organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing – sequence: 15 givenname: Z -M surname: Li fullname: Li, Z -M organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing – sequence: 16 givenname: F. surname: Shan fullname: Shan, F. organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing – sequence: 17 givenname: Z -D surname: Bu fullname: Bu, Z -D organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing – sequence: 18 givenname: J. surname: Tian fullname: Tian, J. email: jie.tian@ia.ac.cn organization: CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing – sequence: 19 givenname: J.-F. surname: Ji fullname: Ji, J.-F. email: jijiafu@hsc.pku.edu.cn organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30689702$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkVFr1TAUx4NM3N300VfJoy_d0iZp0xdBpk5h4Is-h9zk9C7SJjVJO7aP4Kf2zHsdKgwhUHL6O_9zyO-EHIUYgJCXNTurWc_PTcCCPZ_cHWP1E7KpZdtXion6iGxY3_Cqk1wck5OcvzHG2r7pn5FjzlrVd6zZkB_vYIUxzhOEQk1wdDWjd6b4GGgcsEJ9cH71bsH6HTga4hR3yUy0ROoddvnhlkZrl7HQGZIvuJ4Z6QTFZDw-YwCdMRDRTG98uabGrSZYzNohkryl9v6anpOngxkzvDh8T8nXD--_XHysrj5ffrp4e1VZ0apSKe62g5TSSui3TEhgSjGwDR-MVUp0pud22zDZqYYNrlWu6xxThrcwABfC8VPyZp87L9sJnMXFkhn1nPxk0q2Oxuu__wR_rXdx1a0QTStrDHh9CEjx-wK56MlnC-NoAsQl66bueoEvLRWir_6c9TDktwAEqj1gU8w5wfCA1EzfC9Z7wXovGHn-D299-aULV_Xjo12HjeMy_3dAt0cBFaweks4W3aEun8AW7aJ_pPMnus_Thw |
CitedBy_id | crossref_primary_10_2147_JIR_S414786 crossref_primary_10_1002_cncr_32490 crossref_primary_10_1016_j_ebiom_2021_103522 crossref_primary_10_3389_fonc_2022_853948 crossref_primary_10_1007_s00261_023_03802_7 crossref_primary_10_1245_s10434_020_08255_6 crossref_primary_10_3389_fonc_2019_01041 crossref_primary_10_1016_j_ejrad_2020_109268 crossref_primary_10_1016_j_ejrad_2021_109662 crossref_primary_10_3390_cancers15133425 crossref_primary_10_2139_ssrn_4174462 crossref_primary_10_1002_mp_14767 crossref_primary_10_1158_1078_0432_CCR_18_3065 crossref_primary_10_1186_s12883_024_03532_3 crossref_primary_10_1016_j_jncc_2024_12_006 crossref_primary_10_3389_fcimb_2021_744049 crossref_primary_10_1155_2022_5952296 crossref_primary_10_1016_j_radonc_2019_11_023 crossref_primary_10_1007_s00330_024_11082_y crossref_primary_10_1007_s13304_024_01989_y crossref_primary_10_3389_fonc_2020_00888 crossref_primary_10_1007_s00330_022_09219_y crossref_primary_10_1186_s40644_025_00855_3 crossref_primary_10_1016_j_canlet_2025_217509 crossref_primary_10_1109_RBME_2023_3269776 crossref_primary_10_1016_j_cellsig_2023_110636 crossref_primary_10_3389_fmed_2021_744587 crossref_primary_10_1002_cam4_4617 crossref_primary_10_1097_RCT_0000000000001384 crossref_primary_10_1016_j_ejrad_2020_109277 crossref_primary_10_1111_jcmm_16217 crossref_primary_10_3389_fonc_2020_523327 crossref_primary_10_3389_fonc_2021_740732 crossref_primary_10_1186_s12943_024_02196_4 crossref_primary_10_1007_s00330_021_08004_7 crossref_primary_10_1097_MD_0000000000019157 crossref_primary_10_1016_j_ejso_2022_06_034 crossref_primary_10_1007_s00432_023_05096_0 crossref_primary_10_1007_s11605_023_05706_9 crossref_primary_10_3389_fonc_2021_628577 crossref_primary_10_1016_j_radonc_2020_06_010 crossref_primary_10_1109_JBHI_2020_3002805 crossref_primary_10_2147_CMAR_S275422 crossref_primary_10_11569_wcjd_v30_i18_803 crossref_primary_10_1002_jmri_27182 crossref_primary_10_1186_s13244_022_01361_x crossref_primary_10_1186_s12880_023_01089_0 crossref_primary_10_1109_JBHI_2023_3286656 crossref_primary_10_1186_s40644_019_0283_8 crossref_primary_10_1155_2022_4034404 crossref_primary_10_3390_sym15101834 crossref_primary_10_1038_s44321_023_00012_y crossref_primary_10_1016_j_acra_2021_05_005 crossref_primary_10_1016_j_canlet_2024_216901 crossref_primary_10_1007_s00330_023_09854_z crossref_primary_10_1186_s12885_024_12793_7 crossref_primary_10_1007_s00405_021_06730_8 crossref_primary_10_1007_s10278_024_01148_0 crossref_primary_10_3389_fonc_2021_675458 crossref_primary_10_1155_2022_5055684 crossref_primary_10_1016_j_clinimag_2025_110442 crossref_primary_10_1186_s40644_020_00358_3 crossref_primary_10_1109_JBHI_2020_3036722 crossref_primary_10_3389_fonc_2021_657002 crossref_primary_10_1002_cai2_24 crossref_primary_10_1016_j_phrs_2023_106880 crossref_primary_10_1515_pp_2022_0118 crossref_primary_10_3389_fonc_2024_1455914 crossref_primary_10_1259_bjr_20211076 crossref_primary_10_1001_jamanetworkopen_2022_17854 crossref_primary_10_1002_mp_15199 crossref_primary_10_1016_j_ejso_2023_107118 crossref_primary_10_3389_fonc_2019_01050 crossref_primary_10_1007_s00330_019_06621_x crossref_primary_10_1097_RCT_0000000000001600 crossref_primary_10_1007_s11605_023_05671_3 crossref_primary_10_1177_1559325819894179 crossref_primary_10_1016_j_eclinm_2022_101380 crossref_primary_10_3748_wjg_v29_i15_2310 crossref_primary_10_3389_fonc_2020_00057 crossref_primary_10_1007_s00261_023_03848_7 crossref_primary_10_1007_s00405_023_08084_9 crossref_primary_10_1016_j_crad_2022_01_038 crossref_primary_10_1186_s12916_019_1422_6 crossref_primary_10_3390_cancers13112522 crossref_primary_10_1007_s00261_024_04343_3 crossref_primary_10_1007_s12072_023_10630_w crossref_primary_10_1016_j_radonc_2020_06_050 crossref_primary_10_7717_peerj_15277 crossref_primary_10_1259_bjr_20190558 crossref_primary_10_14245_ns_2448082_041 crossref_primary_10_3390_cancers12082236 crossref_primary_10_2139_ssrn_4142309 crossref_primary_10_1002_ctm2_522 crossref_primary_10_3389_fonc_2022_882584 crossref_primary_10_1186_s13048_022_01066_1 crossref_primary_10_2139_ssrn_4117355 crossref_primary_10_1007_s11604_022_01360_4 crossref_primary_10_1007_s13721_024_00448_3 crossref_primary_10_1016_j_trim_2023_101793 crossref_primary_10_1186_s12880_021_00587_3 crossref_primary_10_1016_j_ebiom_2021_103671 crossref_primary_10_1016_j_ebiom_2023_104522 crossref_primary_10_1038_s41571_024_00892_0 crossref_primary_10_3389_fped_2022_927885 crossref_primary_10_1007_s00330_019_06629_3 crossref_primary_10_1007_s00261_024_04303_x crossref_primary_10_1007_s00261_021_03287_2 crossref_primary_10_1007_s11547_024_01783_1 crossref_primary_10_12677_ACM_2023_13112547 crossref_primary_10_1109_JBHI_2020_3034296 crossref_primary_10_1002_advs_202411490 crossref_primary_10_1016_j_ejrad_2019_02_032 crossref_primary_10_1172_JCI175834 crossref_primary_10_1007_s10120_021_01246_w crossref_primary_10_1136_bmjopen_2023_075680 crossref_primary_10_1007_s00261_021_03359_3 crossref_primary_10_3390_cancers14122856 crossref_primary_10_1245_s10434_023_14478_0 crossref_primary_10_1016_j_intimp_2023_109737 crossref_primary_10_1186_s12872_022_02960_8 crossref_primary_10_3389_fonc_2022_949511 crossref_primary_10_1007_s11547_023_01702_w crossref_primary_10_1016_j_ejrad_2023_110719 crossref_primary_10_1016_j_compeleceng_2019_106449 crossref_primary_10_1259_bjr_20201088 crossref_primary_10_1200_JCO_21_02745 crossref_primary_10_1038_s41598_024_79252_y crossref_primary_10_35712_aig_v1_i2_37 crossref_primary_10_1016_j_ejso_2020_11_132 crossref_primary_10_1245_s10434_021_10763_y crossref_primary_10_1016_j_tranon_2019_06_005 crossref_primary_10_1186_s12957_023_03188_2 crossref_primary_10_3389_fonc_2021_659981 crossref_primary_10_1016_j_eclinm_2022_101348 crossref_primary_10_1007_s13246_022_01170_y crossref_primary_10_1016_j_gerinurse_2024_06_010 crossref_primary_10_1016_j_heliyon_2024_e25535 crossref_primary_10_1002_smtd_202300681 crossref_primary_10_3389_fonc_2021_625646 crossref_primary_10_1097_CM9_0000000000000360 crossref_primary_10_1007_s00330_024_10699_3 crossref_primary_10_1016_j_clbc_2024_02_001 crossref_primary_10_1038_s41598_023_42916_2 crossref_primary_10_1155_2021_1040374 crossref_primary_10_1186_s12880_023_00991_x crossref_primary_10_3390_bioengineering11100973 crossref_primary_10_1007_s00330_021_07962_2 crossref_primary_10_1038_s41598_020_67378_8 crossref_primary_10_1097_RCT_0000000000001550 crossref_primary_10_1007_s11432_020_2849_3 crossref_primary_10_1155_2022_2464640 crossref_primary_10_1016_j_heliyon_2024_e29249 crossref_primary_10_1007_s10554_020_01896_4 crossref_primary_10_1093_gastro_goac064 crossref_primary_10_1155_2020_1418978 crossref_primary_10_1097_JS9_0000000000001337 crossref_primary_10_1016_j_annonc_2020_04_003 crossref_primary_10_1080_17474124_2023_2166490 crossref_primary_10_3389_fonc_2024_1476340 crossref_primary_10_3389_fonc_2021_765652 crossref_primary_10_1016_j_acra_2019_10_020 crossref_primary_10_1053_j_gastro_2024_08_007 crossref_primary_10_1245_s10434_024_15631_z crossref_primary_10_1002_uog_22087 crossref_primary_10_1186_s12885_022_10261_8 crossref_primary_10_32604_biocell_2021_015867 crossref_primary_10_1038_s41598_025_92974_x crossref_primary_10_1109_JBHI_2021_3087634 crossref_primary_10_3233_JIFS_233510 crossref_primary_10_3389_fonc_2021_752672 crossref_primary_10_3389_fonc_2023_1167602 crossref_primary_10_1186_s12935_025_03756_4 crossref_primary_10_1007_s00259_022_05793_x crossref_primary_10_1186_s12885_021_08672_0 crossref_primary_10_3390_cancers16010194 crossref_primary_10_1016_j_ejrad_2019_04_022 crossref_primary_10_1186_s40644_020_00320_3 crossref_primary_10_1177_1073274820968900 crossref_primary_10_3389_fneur_2019_00745 crossref_primary_10_1245_s10434_019_07812_y crossref_primary_10_1016_j_jss_2021_03_053 crossref_primary_10_3389_fonc_2020_550526 crossref_primary_10_1007_s00330_019_06368_5 crossref_primary_10_1016_j_ejrad_2020_109205 crossref_primary_10_1007_s00330_021_07902_0 crossref_primary_10_1186_s12967_022_03232_x crossref_primary_10_3389_fonc_2022_830688 crossref_primary_10_34133_hds_0005 crossref_primary_10_1016_j_ejso_2024_109547 crossref_primary_10_1016_j_canlet_2025_217555 crossref_primary_10_3389_fonc_2022_870544 crossref_primary_10_1016_j_ejrad_2019_07_018 crossref_primary_10_1177_15330338211004924 crossref_primary_10_4253_wjge_v13_i5_125 crossref_primary_10_3389_fonc_2022_946038 crossref_primary_10_1186_s12893_020_00969_4 crossref_primary_10_3389_fonc_2020_601869 crossref_primary_10_1186_s12880_020_00470_7 crossref_primary_10_1002_jmri_27132 crossref_primary_10_1016_j_crad_2024_10_008 crossref_primary_10_1155_2022_8548760 crossref_primary_10_1097_MD_0000000000034702 crossref_primary_10_1097_JS9_0000000000001213 crossref_primary_10_1007_s00330_021_08292_z crossref_primary_10_1007_s11548_022_02698_w crossref_primary_10_1093_comjnl_bxaa148 crossref_primary_10_1186_s40644_023_00584_5 crossref_primary_10_1007_s44178_022_00004_x crossref_primary_10_3390_cancers15010063 crossref_primary_10_1007_s00259_021_05326_y crossref_primary_10_1002_ehf2_12703 crossref_primary_10_1097_MNM_0000000000001742 crossref_primary_10_1186_s12879_021_06614_6 crossref_primary_10_1007_s00330_025_11491_7 crossref_primary_10_1016_j_soc_2024_12_005 crossref_primary_10_1155_2021_2987080 crossref_primary_10_1007_s10147_020_01852_1 crossref_primary_10_1038_s41698_021_00205_z crossref_primary_10_1038_s41467_020_20429_0 crossref_primary_10_1097_SLA_0000000000004229 crossref_primary_10_3389_fonc_2019_01330 crossref_primary_10_1109_ACCESS_2019_2937907 crossref_primary_10_3389_fsurg_2022_916001 crossref_primary_10_1097_MD_0000000000033942 crossref_primary_10_1016_j_ejrad_2019_03_010 crossref_primary_10_1016_j_gie_2022_07_019 crossref_primary_10_1186_s12880_019_0355_z crossref_primary_10_2147_IJGM_S419039 crossref_primary_10_52927_jdcr_2023_11_3_130 crossref_primary_10_1245_s10434_024_16387_2 crossref_primary_10_1007_s12094_024_03417_4 crossref_primary_10_3389_fonc_2019_00829 crossref_primary_10_3389_fonc_2021_682456 crossref_primary_10_1186_s40644_024_00711_w crossref_primary_10_1038_s41571_022_00675_5 crossref_primary_10_1097_RCT_0000000000001117 crossref_primary_10_1186_s40644_024_00744_1 crossref_primary_10_1002_mp_14216 crossref_primary_10_1088_1361_6560_acec2d crossref_primary_10_3389_fonc_2019_01007 crossref_primary_10_3389_fonc_2020_00563 crossref_primary_10_1016_j_intonc_2024_10_003 crossref_primary_10_3389_fgene_2022_909175 crossref_primary_10_1038_s41598_024_82595_1 crossref_primary_10_3348_kjr_2023_0840 crossref_primary_10_3389_fonc_2020_01416 crossref_primary_10_1186_s12943_021_01396_6 crossref_primary_10_1002_mp_15094 crossref_primary_10_18632_aging_104082 crossref_primary_10_7717_peerj_17602 crossref_primary_10_1007_s00330_023_10042_2 crossref_primary_10_1136_jitc_2020_000550 crossref_primary_10_1016_j_ejrad_2020_108825 crossref_primary_10_1038_s41390_023_02553_x crossref_primary_10_1002_cac2_12516 crossref_primary_10_3389_fonc_2021_646190 crossref_primary_10_3390_cancers15112874 crossref_primary_10_1155_2021_8023490 crossref_primary_10_1155_2022_2259373 crossref_primary_10_1007_s00261_024_04306_8 crossref_primary_10_1016_j_neunet_2023_04_030 crossref_primary_10_1088_1361_6560_ab489f crossref_primary_10_2139_ssrn_4000463 crossref_primary_10_1007_s11604_022_01352_4 crossref_primary_10_1016_j_acra_2022_09_001 crossref_primary_10_1016_S2589_7500_22_00040_1 crossref_primary_10_3389_fonc_2020_01524 crossref_primary_10_3390_cancers15235630 crossref_primary_10_3390_onco3020006 crossref_primary_10_1002_mp_14350 crossref_primary_10_1016_j_tranon_2021_101113 crossref_primary_10_1186_s12880_022_00868_5 crossref_primary_10_1177_0284185121994695 crossref_primary_10_3389_fonc_2020_590492 crossref_primary_10_1097_PAI_0000000000001152 crossref_primary_10_1002_cam4_3215 crossref_primary_10_1177_1758835920971416 crossref_primary_10_1007_s12028_021_01320_2 crossref_primary_10_1016_j_gie_2020_11_014 crossref_primary_10_3389_fonc_2022_949111 crossref_primary_10_3389_fonc_2021_777760 crossref_primary_10_1016_j_crad_2023_03_016 crossref_primary_10_1186_s12957_019_1750_1 crossref_primary_10_1007_s10120_023_01463_5 crossref_primary_10_3389_fonc_2019_01265 crossref_primary_10_3389_fendo_2024_1264952 crossref_primary_10_3390_jcm12041292 crossref_primary_10_1136_egastro_2023_100016 crossref_primary_10_1177_11795549221142095 crossref_primary_10_3389_fonc_2020_558428 crossref_primary_10_1186_s13244_024_01818_1 crossref_primary_10_1016_j_acra_2023_03_023 crossref_primary_10_3389_fonc_2019_01250 crossref_primary_10_1007_s00261_024_04420_7 crossref_primary_10_1002_mp_15437 crossref_primary_10_1002_mp_16647 crossref_primary_10_1007_s00381_022_05507_6 crossref_primary_10_1177_15353702221113828 crossref_primary_10_1177_15330338221100355 crossref_primary_10_1016_j_compbiomed_2021_105173 crossref_primary_10_3389_fonc_2020_00412 |
Cites_doi | 10.1038/nrclinonc.2017.141 10.1016/j.ejso.2013.10.019 10.1016/j.crad.2012.07.015 10.1159/000236018 10.1186/s12957-016-0805-9 10.1002/jso.21685 10.1093/annonc/mdx034 10.1093/annonc/mdw350 10.1186/1471-2407-13-57 10.1016/j.ejso.2006.03.003 10.1245/s10434-017-5997-x 10.1158/1078-0432.CCR-17-1038 10.6004/jnccn.2013.0070 10.1148/radiol.2532082272 10.1371/journal.pone.0194755 10.1200/JCO.2015.65.9128 10.1016/S1470-2045(15)00553-7 10.1016/j.ejrad.2017.04.007 10.1038/nrc1098 |
ContentType | Journal Article |
Copyright | 2019 THE AUTHORS The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. 2019 The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. |
Copyright_xml | – notice: 2019 THE AUTHORS – notice: The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. 2019 – notice: The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. |
DBID | 6I. AAFTH TOX AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1093/annonc/mdz001 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Oxford Journals Open Access Collection CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: TOX name: Oxford Journals Open Access Collection url: https://academic.oup.com/journals/ sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Novel patterns of response under immunotherapy |
EISSN | 1569-8041 |
EndPage | 438 |
ExternalDocumentID | PMC6442651 30689702 10_1093_annonc_mdz001 10.1093/annonc/mdz001 S0923753419310816 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: National Natural Science Foundation of China grantid: 81771924; 81501616; 81227901; 81671851; 81527805; 61671449; 61622117 funderid: 10.13039/501100001809 – fundername: Instrument Developing Project of the Chinese Academy of Sciences grantid: YZ201502 – fundername: Youth Innovation Promotion Association CAS grantid: 2017175 funderid: 10.13039/501100004739 – fundername: Beijing Municipal Science and Technology Commission grantid: Z171100000117023; Z161100002616022 funderid: 10.13039/501100009592 – fundername: Beijing Natural Science Foundation grantid: L182061; Z180001 funderid: 10.13039/501100004826 – fundername: National Key R&D Program of China grantid: 2017YFA0205200; 2017YFC1308700; 2017YFC1309100; 2016YFC0103803; 2017YFA0700401 – fundername: ; ; grantid: L182061; Z180001 – fundername: ; grantid: YZ201502 – fundername: ; ; grantid: Z171100000117023; Z161100002616022 – fundername: ; ; grantid: 81771924; 81501616; 81227901; 81671851; 81527805; 61671449; 61622117 – fundername: ; ; grantid: 2017175 – fundername: ; grantid: 2017YFA0205200; 2017YFC1308700; 2017YFC1309100; 2016YFC0103803; 2017YFA0700401 |
GroupedDBID | --- -E4 .2P .86 .I3 .XZ .ZR 08P 0R~ 0U7 1TH 23M 2WC 4.4 482 48X 53G 5GY 5VS 5WA 6.Y 6I. 6J9 70D AABJS AABMN AAEDW AAESY AAFTH AAIAV AAIYJ AAJKP AAJQQ AAKAS AAKUH AAMVS AAOGV AAPNW AAUQX AAXUO ABEUO ABIXL ABJNI ABKDP ABLJU ABNKS ABOCM ABQLI ABQTQ ABSAR ABSMQ ABVKL ABZBJ ACGFO ACGFS ACIMA ACMRT ACPQN ACPRK ACUFI ACUTO ADBBV ADEIU ADEYI ADHKW ADHZD ADJQC ADOCK ADORX ADQLU ADRIX ADRTK ADYVW ADZCM ADZXQ AEGPL AEGXH AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AEWNT AFIYH AFOFC AFXEN AGINJ AGKEF AGKRT AGSYK AHMBA AHXPO AIAGR AIJHB AIKOY AITUG ALMA_UNASSIGNED_HOLDINGS ALUQC AMRAJ APIBT APWMN AQKUS ASMCH ASPBG ATTQO AVWKF AWCFO AXUDD AZFZN AZQFJ BAWUL BAYMD BEYMZ BGNMA BGYMP BHONS BTRTY BVRKM BZKNY C1A CAG CASEJ CDBKE CKLRP COF CS3 CZ4 DAKXR DIK DILTD DL5 DPORF DPPUQ D~K E3Z EBS EE~ EJD EX3 F9B FDB FEDTE GJXCC GX1 H5~ HAR HVGLF HW0 HZ~ I09 IH2 IHE IOX J21 KAQDR KC5 KDC KOM KOP KQ8 KSI KSN LAK M-Z M41 M49 M4Y MBLQV MHKGH N9A NCXOZ NGC NOYVH NTWIH NU- NU0 NVLIB O9- OAWHX ODMLO OJQWA OK1 OVD P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RNI ROL ROX ROZ RPX RW1 RXO RZC RZE RZF RZO SDH TCURE TEORI TJX TMA TR2 U2A W8F WOQ WOW X7H YAYTL YFH YKOAZ ZKX ZXP ~91 0SF AALRI ADVLN AFETI TOX AAGQS AAYWO AAYXX ABNGD ACUKT ACVFH ADCNI AEHUL AEUPX AFJKZ AFPUW AFSHK AGCQF AGQPQ AIGII AKBMS AKRWK AKYEP APXCP CITATION H13 CGR CUY CVF ECM EIF NPM 7X8 5PM EFKBS |
ID | FETCH-LOGICAL-c468t-83dbf555c5e9b045e0880ec23fac8847a93cb2057820fd68d77d08a36efe344d3 |
IEDL.DBID | TOX |
ISSN | 0923-7534 1569-8041 |
IngestDate | Thu Aug 21 13:52:14 EDT 2025 Fri Jul 11 03:31:29 EDT 2025 Wed Feb 19 02:29:15 EST 2025 Thu Apr 24 23:03:14 EDT 2025 Tue Jul 01 02:09:25 EDT 2025 Wed Sep 11 04:52:49 EDT 2024 Fri Feb 23 02:45:48 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | radiomic nomogram occult peritoneal metastasis advanced gastric cancer |
Language | English |
License | http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. https://www.elsevier.com/tdm/userlicense/1.0 The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c468t-83dbf555c5e9b045e0880ec23fac8847a93cb2057820fd68d77d08a36efe344d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors D. Dong, L. Tang, Z.-Y. Li, M.-J. Fang, J.-B. Gao and X.-H. Shan contributed equally to this work. |
OpenAccessLink | https://dx.doi.org/10.1093/annonc/mdz001 |
PMID | 30689702 |
PQID | 2179469258 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6442651 proquest_miscellaneous_2179469258 pubmed_primary_30689702 crossref_primary_10_1093_annonc_mdz001 crossref_citationtrail_10_1093_annonc_mdz001 oup_primary_10_1093_annonc_mdz001 elsevier_sciencedirect_doi_10_1093_annonc_mdz001 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-03-01 |
PublicationDateYYYYMMDD | 2019-03-01 |
PublicationDate_xml | – month: 03 year: 2019 text: 2019-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Annals of oncology |
PublicationTitleAlternate | Ann Oncol |
PublicationYear | 2019 |
Publisher | Elsevier Ltd Oxford University Press |
Publisher_xml | – name: Elsevier Ltd – name: Oxford University Press |
References | Coccolini, Cotte, Glehen (bb0010) 2014; 40 Ajani, Bentrem, Besh (bb0035) 2013; 11 Li, Oh, Kim (bb0095) 2009; 77 Fujitani, Yang, Mizusawa (bb0015) 2016; 17 Smyth, Verheij, Allum (bb0020) 2016; 27 Liu, Zhang, Shi (bb0065) 2017; 23 Hur, Lee, Jung (bb0045) 2010; 102 Liu, Yuan, Geng (bb0090) 2015; 8 Ma, Fang, Huang (bb0075) 2017; 91 Yamaguchi, Satoh, Ishigami (bb0105) 2017; 24 Burbidge, Mahady, Naik (bb0030) 2013; 68 Fidler (bb0080) 2003; 3 Huang, Liang, He (bb0070) 2016; 34 Yonemura, Bandou, Kawamura (bb0085) 2006; 32 Huang, Sun, Wang (bb0040) 2013; 13 Limkin, Sun, Dercle (bb0055) 2017; 28 Lambin, Leijenaar, Deist (bb0060) 2017; 14 Luo, Gao, Song (bb0100) 2016; 14 Kim, Kim, Yun (bb0050) 2018; 13 Kim, Kim, Kim (bb0025) 2009; 253 Smyth (10.1093/annonc/mdz001_bb0020) 2016; 27 Liu (10.1093/annonc/mdz001_bb0090) 2015; 8 Coccolini (10.1093/annonc/mdz001_bb0010) 2014; 40 Fujitani (10.1093/annonc/mdz001_bb0015) 2016; 17 Huang (10.1093/annonc/mdz001_bb0070) 2016; 34 Yamaguchi (10.1093/annonc/mdz001_bb0105) 2017; 24 Huang (10.1093/annonc/mdz001_bb0040) 2013; 13 Lambin (10.1093/annonc/mdz001_bb0060) 2017; 14 Yonemura (10.1093/annonc/mdz001_bb0085) 2006; 32 Ajani (10.1093/annonc/mdz001_bb0035) 2013; 11 Hur (10.1093/annonc/mdz001_bb0045) 2010; 102 Ma (10.1093/annonc/mdz001_bb0075) 2017; 91 Kim (10.1093/annonc/mdz001_bb0050) 2018; 13 Fidler (10.1093/annonc/mdz001_bb0080) 2003; 3 Kim (10.1093/annonc/mdz001_bb0025) 2009; 253 Liu (10.1093/annonc/mdz001_bb0065) 2017; 23 Luo (10.1093/annonc/mdz001_bb0100) 2016; 14 Burbidge (10.1093/annonc/mdz001_bb0030) 2013; 68 Limkin (10.1093/annonc/mdz001_bb0055) 2017; 28 Li (10.1093/annonc/mdz001_bb0095) 2009; 77 |
References_xml | – volume: 34 start-page: 2157 year: 2016 end-page: 2164 ident: bb0070 article-title: Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer publication-title: J Clin Oncol – volume: 40 start-page: 12 year: 2014 end-page: 26 ident: bb0010 article-title: Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials publication-title: Eur J Surg Oncol – volume: 28 start-page: 1191 year: 2017 end-page: 1206 ident: bb0055 article-title: Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology publication-title: Ann Oncol – volume: 14 start-page: 49 year: 2016 ident: bb0100 article-title: Clinicopathologic characteristics and prognosis of Borrmann type IV gastric cancer: a meta-analysis publication-title: World J Surg Oncol – volume: 24 start-page: 3345 year: 2017 end-page: 3352 ident: bb0105 article-title: Peritoneal lavage CEA mRNA levels predict conversion gastrectomy outcomes after induction chemotherapy with intraperitoneal paclitaxel in gastric cancer patients with peritoneal metastasis publication-title: Ann Surg Oncol – volume: 11 start-page: 531 year: 2013 end-page: 546 ident: bb0035 article-title: Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines publication-title: J Natl Compr Canc Netw – volume: 14 start-page: 749 year: 2017 ident: bb0060 article-title: Radiomics: the bridge between medical imaging and personalized medicine publication-title: Nat Rev Clin Oncol – volume: 253 start-page: 407 year: 2009 end-page: 415 ident: bb0025 article-title: Peritoneal metastasis: detection with 16- or 64-detector row CT in patients undergoing surgery for gastric cancer publication-title: Radiology – volume: 3 start-page: 453 year: 2003 end-page: 458 ident: bb0080 article-title: The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited publication-title: Nat Rev Cancer – volume: 17 start-page: 309 year: 2016 end-page: 318 ident: bb0015 article-title: Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial publication-title: Lancet Oncol – volume: 8 start-page: 12877 year: 2015 end-page: 12884 ident: bb0090 article-title: Morphological study and comprehensive cellular constituents of milky spots in the human omentum publication-title: Int J Clin Exp Pathol – volume: 27 start-page: v38 year: 2016 end-page: v49 ident: bb0020 article-title: Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up publication-title: Ann Oncol – volume: 68 start-page: 251 year: 2013 end-page: 255 ident: bb0030 article-title: The role of CT and staging laparoscopy in the staging of gastric cancer publication-title: Clin Radiol – volume: 13 start-page: 57. year: 2013 ident: bb0040 article-title: Factors associated with peritoneal metastasis innon-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected database publication-title: BMC Cancer – volume: 13 start-page: e0194755 year: 2018 ident: bb0050 article-title: Could texture features from preoperative CT image be used for predicting occult peritoneal carcinomatosis in patients with advanced gastric cancer? publication-title: PLoS One – volume: 32 start-page: 602 year: 2006 end-page: 606 ident: bb0085 article-title: Quantitative prognostic indicators of peritoneal dissemination of gastric cancer publication-title: Eur J Surg Oncol – volume: 23 start-page: 7253 year: 2017 end-page: 7262 ident: bb0065 article-title: Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer publication-title: Clin Cancer Res – volume: 91 start-page: 142 year: 2017 end-page: 147 ident: bb0075 article-title: CT-based radiomics signature for differentiating Borrmann type IV gastric cancer from primary gastric lymphoma publication-title: Eur J Radiol – volume: 102 start-page: 753 year: 2010 end-page: 757 ident: bb0045 article-title: Predicting factors of unexpected peritoneal seeding in locally advanced gastric cancer: indications for staging laparoscopy publication-title: J Surg Oncol – volume: 77 start-page: 197 year: 2009 end-page: 204 ident: bb0095 article-title: Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer publication-title: Oncology – volume: 14 start-page: 749 issue: 12 year: 2017 ident: 10.1093/annonc/mdz001_bb0060 article-title: Radiomics: the bridge between medical imaging and personalized medicine publication-title: Nat Rev Clin Oncol doi: 10.1038/nrclinonc.2017.141 – volume: 40 start-page: 12 issue: 1 year: 2014 ident: 10.1093/annonc/mdz001_bb0010 article-title: Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2013.10.019 – volume: 68 start-page: 251 issue: 3 year: 2013 ident: 10.1093/annonc/mdz001_bb0030 article-title: The role of CT and staging laparoscopy in the staging of gastric cancer publication-title: Clin Radiol doi: 10.1016/j.crad.2012.07.015 – volume: 77 start-page: 197 issue: 3–4 year: 2009 ident: 10.1093/annonc/mdz001_bb0095 article-title: Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer publication-title: Oncology doi: 10.1159/000236018 – volume: 14 start-page: 49 year: 2016 ident: 10.1093/annonc/mdz001_bb0100 article-title: Clinicopathologic characteristics and prognosis of Borrmann type IV gastric cancer: a meta-analysis publication-title: World J Surg Oncol doi: 10.1186/s12957-016-0805-9 – volume: 8 start-page: 12877 year: 2015 ident: 10.1093/annonc/mdz001_bb0090 article-title: Morphological study and comprehensive cellular constituents of milky spots in the human omentum publication-title: Int J Clin Exp Pathol – volume: 102 start-page: 753 issue: 7 year: 2010 ident: 10.1093/annonc/mdz001_bb0045 article-title: Predicting factors of unexpected peritoneal seeding in locally advanced gastric cancer: indications for staging laparoscopy publication-title: J Surg Oncol doi: 10.1002/jso.21685 – volume: 28 start-page: 1191 issue: 6 year: 2017 ident: 10.1093/annonc/mdz001_bb0055 article-title: Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology publication-title: Ann Oncol doi: 10.1093/annonc/mdx034 – volume: 27 start-page: v38 issue: Suppl 5 year: 2016 ident: 10.1093/annonc/mdz001_bb0020 article-title: Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up publication-title: Ann Oncol doi: 10.1093/annonc/mdw350 – volume: 13 start-page: 57. year: 2013 ident: 10.1093/annonc/mdz001_bb0040 article-title: Factors associated with peritoneal metastasis innon-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected database publication-title: BMC Cancer doi: 10.1186/1471-2407-13-57 – volume: 32 start-page: 602 issue: 6 year: 2006 ident: 10.1093/annonc/mdz001_bb0085 article-title: Quantitative prognostic indicators of peritoneal dissemination of gastric cancer publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2006.03.003 – volume: 24 start-page: 3345 issue: 11 year: 2017 ident: 10.1093/annonc/mdz001_bb0105 article-title: Peritoneal lavage CEA mRNA levels predict conversion gastrectomy outcomes after induction chemotherapy with intraperitoneal paclitaxel in gastric cancer patients with peritoneal metastasis publication-title: Ann Surg Oncol doi: 10.1245/s10434-017-5997-x – volume: 23 start-page: 7253 issue: 23 year: 2017 ident: 10.1093/annonc/mdz001_bb0065 article-title: Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-17-1038 – volume: 11 start-page: 531 issue: 5 year: 2013 ident: 10.1093/annonc/mdz001_bb0035 article-title: Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines publication-title: J Natl Compr Canc Netw doi: 10.6004/jnccn.2013.0070 – volume: 253 start-page: 407 issue: 2 year: 2009 ident: 10.1093/annonc/mdz001_bb0025 article-title: Peritoneal metastasis: detection with 16- or 64-detector row CT in patients undergoing surgery for gastric cancer publication-title: Radiology doi: 10.1148/radiol.2532082272 – volume: 13 start-page: e0194755 issue: 3 year: 2018 ident: 10.1093/annonc/mdz001_bb0050 article-title: Could texture features from preoperative CT image be used for predicting occult peritoneal carcinomatosis in patients with advanced gastric cancer? publication-title: PLoS One doi: 10.1371/journal.pone.0194755 – volume: 34 start-page: 2157 issue: 18 year: 2016 ident: 10.1093/annonc/mdz001_bb0070 article-title: Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2015.65.9128 – volume: 17 start-page: 309 issue: 3 year: 2016 ident: 10.1093/annonc/mdz001_bb0015 article-title: Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(15)00553-7 – volume: 91 start-page: 142 year: 2017 ident: 10.1093/annonc/mdz001_bb0075 article-title: CT-based radiomics signature for differentiating Borrmann type IV gastric cancer from primary gastric lymphoma publication-title: Eur J Radiol doi: 10.1016/j.ejrad.2017.04.007 – volume: 3 start-page: 453 issue: 6 year: 2003 ident: 10.1093/annonc/mdz001_bb0080 article-title: The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited publication-title: Nat Rev Cancer doi: 10.1038/nrc1098 |
SSID | ssj0006929 |
Score | 2.6787581 |
Snippet | Occult peritoneal metastasis (PM) in advanced gastric cancer (AGC) patients is highly possible to be missed on computed tomography (CT) images. Patients with... Abstract Background Occult peritoneal metastasis (PM) in advanced gastric cancer (AGC) patients is highly possible to be missed on computed tomography (CT)... |
SourceID | pubmedcentral proquest pubmed crossref oup elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 431 |
SubjectTerms | advanced gastric cancer Female Humans Laparoscopy Male Middle Aged Neoplasm Metastasis Neoplasm Staging Nomograms occult peritoneal metastasis Original Peritoneal Neoplasms - diagnosis Peritoneal Neoplasms - diagnostic imaging Peritoneal Neoplasms - pathology Peritoneal Neoplasms - secondary Peritoneum - diagnostic imaging Peritoneum - pathology Radiometry - methods radiomic nomogram Stomach Neoplasms - diagnosis Stomach Neoplasms - diagnostic imaging Stomach Neoplasms - pathology Tomography Scanners, X-Ray Computed |
Title | Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer |
URI | https://dx.doi.org/10.1093/annonc/mdz001 https://www.ncbi.nlm.nih.gov/pubmed/30689702 https://www.proquest.com/docview/2179469258 https://pubmed.ncbi.nlm.nih.gov/PMC6442651 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwELYQB8Slaksf2wcyUsWJSN74EftYIRBQ0V5A2lvkjO02UkkQCYfyE_qrO46z0S7tih6T2E7kmdjfeGa-IeRTsJVQc2syDYJlArzLbJjLLHgm_VxrByZmI19-VWfX4mIhF-N5R_cPF77hsR5L2wAa6A9sSNTCDTiS5F99W0xLrjJ5ItXLeYb4W4xkmn_13rT5rOW2rUDMx5GSK1vP6XPybMSM9HMS8guy5ZuXZOdy9Irvkd8rkT_UNo6i9tSpVhJtA96h9ZR2VT94R5v2ZojKon1L6yFTN_yiLUQWDhqZjyNBN77wxvcWwWNXdzgAHRlYOxqPbukydoB-t7HyB1CIl3evyPXpydXxWTbWWMhAKN1nmrsqSClBelMhvPO46jAPOQ8WNO5c1nCochZJ71lwSruicExbrnzwXAjHX5NtnGD_ltCCK-YUWF1UaNOBNdblILSwoBj3RZiRo-XklzASkMc6GD_L5AjnZZJVmWQ1I4dT89vEvLGpIVtKshxhQ4IDJWrSpi4HKPGnhj1Y6kOJv1z0o9jGt_ddmcdFDFVO6hl5k_RjGgotMG0Kls9IsaY5U4NI573-pKl_DLTeiExzJefv_uPb3pNdBG4mxcJ9INv93b3_iOCor_bRLDj_sj_8Hn8AgKcW-w |
linkProvider | Oxford University Press |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+and+validation+of+an+individualized+nomogram+to+identify+occult+peritoneal+metastasis+in+patients+with+advanced+gastric+cancer&rft.jtitle=Annals+of+oncology&rft.au=Dong%2C+D&rft.au=Tang%2C+L&rft.au=Li%2C+Z+-Y&rft.au=Fang%2C+M+-J&rft.date=2019-03-01&rft.pub=Oxford+University+Press&rft.issn=0923-7534&rft.eissn=1569-8041&rft.volume=30&rft.issue=3&rft.spage=431&rft.epage=438&rft_id=info:doi/10.1093%2Fannonc%2Fmdz001&rft.externalDocID=10.1093%2Fannonc%2Fmdz001 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon |